Popular Press News for December 14, 2022
advertisement
- Type 1 Diabetes Doesn’t Have to Hold Kids Back in School
- Ozempic diabetes drug faces shortage after endorsements by celebs
- New Agent: ‘First Step’ Toward Delaying Progression of Type 1 Diabetes
- Type 1 Diabetes and Hypoglycemia: Causes and Treatments
- Technosphere Insulin for Type 1 Diabetes
- Mark Cuban’s Cost Plus Drug Company mulling affordable insulin program, wants user feedback
- 5 things to know about the cost of insulin
- Untangling the Price of Insulin